Development of a Novel T-tube Frontal Sinus Irrigation Catheter

Rotenberg, Brian; Ioanidis, Khrystyna; Sowerby, Leigh J.

doi:10.2500/ajra.2016.30.4345

Cited by 10 publications

(11 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Some authors proposed that stenting should be considered when the neo‐ostium is <5 mm or has been significantly demucosalized (>50%), and that stents should be maintained for at least 6 weeks 2211,2222 . Numerous case series 2223–2231 have evaluated soft silicone stents, either fashioned or proprietary, in the postoperative frontal sinus. These uncontrolled studies and have found that inert frontal sinus stents reduce stenosis and reoperation rates.…”

Section: Surgery For Chronic Rhinosinusitismentioning

confidence: 99%

International consensus statement on allergy and rhinology: rhinosinusitis 2021

Orlandi

Kingdom

Smith

et al. 2021

Int Forum Allergy Rhinol

518

479

View full text Add to dashboard Cite

I. Executive Summary Background The 5 years since the publication of the first International Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR‐RS) has witnessed foundational progress in our understanding and treatment of rhinologic disease. These advances are reflected within the more than 40 new topics covered within the ICAR‐RS‐2021 as well as updates to the original 140 topics. This executive summary consolidates the evidence‐based findings of the document. Methods ICAR‐RS presents over 180 topics in the forms of evidence‐based reviews with recommendations (EBRRs), evidence‐based reviews, and literature reviews. The highest grade structured recommendations of the EBRR sections are summarized in this executive summary. Results ICAR‐RS‐2021 covers 22 topics regarding the medical management of RS, which are grade A/B and are presented in the executive summary. Additionally, 4 topics regarding the surgical management of RS are grade A/B and are presented in the executive summary. Finally, a comprehensive evidence‐based management algorithm is provided. Conclusion This ICAR‐RS‐2021 executive summary provides a compilation of the evidence‐based recommendations for medical and surgical treatment of the most common forms of RS.

show abstract

Section: Surgery For Chronic Rhinosinusitismentioning

confidence: 99%

International consensus statement on allergy and rhinology: rhinosinusitis 2021

Orlandi

Kingdom

Smith

et al. 2021

Int Forum Allergy Rhinol

518

479

View full text Add to dashboard Cite

show abstract

“…The study reported a 96.7% patency rate at 6 months, with a high compliance with rinsing regimens. 22 However, because of its shape, this catheter was not primarily designed for smaller frontal sinusotomy or other sinus irrigation. On the other hand, our study showed that the Sinusplint is usable for both maxillary and frontal sinus and its catheter allows effective sinus irrigation (if ostium size is sufficient and sinus walls intact).…”

Section: Discussionmentioning

confidence: 99%

Development of a New Device for Postoperative Self-Irrigation of the Maxillary and Frontal Sinus

et al. 2021

View full text Add to dashboard Cite

Objectives: Nasal saline irrigation is the corner stone of postoperative care after functional endoscopic sinus surgery (FESS) for chronic rhinosinusitis (CRS). However, intrasinus penetration of the saline solution can be challenging and may require difficult head position, particularly for the frontal sinus. Our aim was to evaluate a novel device for direct intrasinus self-irrigation, usable at home for both maxillary and frontal sinus. Methods: Thirty devices were implemented in 23 patients: in the maxillary sinus for 18 patients and in the frontal sinus for 5 patients. The device was removed after 7 days on average (5-10 days), and nasal saline irrigation was carried on with a squeeze bottle for 6 weeks. Retrospective evaluation of the device included: device-related complication, patient satisfaction, and ostial or middle turbinate synechiae at 3 months. Results: No device-related complication (obstruction, displacement, infection, bleeding) occurred. Twenty-one (91.3%) patients were satisfied with the device. Two patients required the help of a nurse for irrigation. No ostial of middle turbinate synechiae was visualized at 3 months. This new endonasal device enables direct intrasinus self-irrigation after FESS for CRS. Conclusion: This preliminary study showed that this device is safe and easy to use. However, further investigations are required to assess its potential role to reduce the risk of synechiae and revision surgery.

show abstract

“…1 Revision rates of 10 to 25% have been reported in the literature, 7 with the “outside-in” procedure achieving a significant reduction in operative time over the conventional “inside-out” approach via the frontal recess. 4 Although other investigators have described the use of silastic sheets 4 and irrigation catheters 8 to improve outcomes, it is not my usual practice to use these. The patient is reviewed 2 weeks after surgery; any remaining bioabsorbable dressing can be removed at that time and further steroid-impregnated material inserted if required.…”

Section: Discussionmentioning

confidence: 99%